Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/10058
|
| Title: | DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: A large cohort study |
| Authors: | Tsai, MC;Li, WM;Huang, CN;Ke, HL;Li, CC;Yeh, HC;Chan, TC;Liang, PI;Yeh, BW;Wu, WJ;Lim, SW;Li, CF |
| Contributors: | National Institute of Cancer Research |
| Abstract: | The migration ability of urothelial carcinoma corresponding to dismal prognosis had not been fully investigated. The interaction of extracellular collagen with a unique transmembrane receptor tyrosine kinase, Discoidin domain receptor 2 (DDR2), was selected by data mining. We arranged real-time reverse transcription polymerase chain reaction assays to evaluate the transcript levels in 26 urinary tract urothelial carcinoma and 26 urinary bladder urothelial carcinoma specimens, showing significantly increase corresponding to advanced primary stage (p = 0.003 and p < 0.001, respectively). An immunohistochemistry analysis and H-score calculation were performed to determine DDR2 expression in 340 urinary tract urothelial carcinoma and 295 urinary bladder urothelial carcinoma. Assessments of the correlation to clinicopathologic features, disease-specific survival, and metastasis-free survival were conducted. The transcript levels in advanced stage were higher than those in early stage and were correlated with poor prognosis. The higher expression was positively correlated to higher pT status (p < 0.001), higher histological grade (urinary tract, p = 0.041; urinary bladder, p < 0.001), greater vascular invasion (p < 0.001), and higher mitotic rate (urinary tract, p = 0.039; urinary bladder, p < 0.001). Higher expression also indicates significantly worse disease-specific survival and metastasis-free survival. In vitro study revealed knockdown of DDR2 resulted in a depletion of cellular viability, migratory, and invasive ability, supporting the oncogenic function of DDR2. |
| Date: | 2016-11 |
| Relation: | Oncotarget. 2016 Nov;7(48):78918-78931. |
| Link to: | http://dx.doi.org/10.18632/oncotarget.12912 |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000389636000060 |
| Cited Times(Scopus): | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84999636174 |
| Appears in Collections: | [其他] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| PUB27793038.pdf | | 2694Kb | Adobe PDF | 225 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
